AAAAAA

   
Results: 1-7 |
Results: 7
RATIONAL DESIGN, SYNTHESIS, AND SERINE-PROTEASE INHIBITORY ACTIVITY OF A NOVEL P-1-ARGININAL DERIVATIVE FEATURING A CONFORMATIONALLY CONSTRAINED P-2-P-3-BICYCLIC LACTAM MOIETY
Authors: TAMURA SY GOLDMAN EA BRUNCK TK RIPKA WC SEMPLE JE
Citation: Sy. Tamura et al., RATIONAL DESIGN, SYNTHESIS, AND SERINE-PROTEASE INHIBITORY ACTIVITY OF A NOVEL P-1-ARGININAL DERIVATIVE FEATURING A CONFORMATIONALLY CONSTRAINED P-2-P-3-BICYCLIC LACTAM MOIETY, Bioorganic & medicinal chemistry letters, 7(3), 1997, pp. 331-336
RATIONAL DESIGN AND SYNTHESIS OF A NOVEL, SELECTIVE CLASS OF THROMBININHIBITORS - P-1-ARGININAL DERIVATIVES INCORPORATING P-3-P-4 QUATERNARY LACTAM DIPEPTIDE SURROGATES
Authors: SEMPLE JE MINAMI NK TAMURA SY BRUNCK TK NUTT RF RIPKA WC
Citation: Je. Semple et al., RATIONAL DESIGN AND SYNTHESIS OF A NOVEL, SELECTIVE CLASS OF THROMBININHIBITORS - P-1-ARGININAL DERIVATIVES INCORPORATING P-3-P-4 QUATERNARY LACTAM DIPEPTIDE SURROGATES, Bioorganic & medicinal chemistry letters, 7(18), 1997, pp. 2421-2426
DESIGN AND SYNTHESIS OF A NOVEL CLASS OF THROMBIN INHIBITORS INCORPORATING HETEROCYCLIC DIPEPTIDE SURROGATES
Authors: TAMURA SY SEMPLE JE REINER JE GOLDMAN EA BRUNCK TK LIMWILBY MS CARPENTER SH ROTE WE OLDESHULTE GL RICHARD BM NUTT RF RIPKA WC
Citation: Sy. Tamura et al., DESIGN AND SYNTHESIS OF A NOVEL CLASS OF THROMBIN INHIBITORS INCORPORATING HETEROCYCLIC DIPEPTIDE SURROGATES, Bioorganic & medicinal chemistry letters, 7(12), 1997, pp. 1543-1548
RATIONAL DESIGN, SYNTHESIS, AND SERINE-PROTEASE INHIBITORY ACTIVITY OF NOVEL P-1-ARGININOYL HETEROCYCLES
Authors: TAMURA SY SHAMBLIN BM BRUNCK TK RIPKA WC
Citation: Sy. Tamura et al., RATIONAL DESIGN, SYNTHESIS, AND SERINE-PROTEASE INHIBITORY ACTIVITY OF NOVEL P-1-ARGININOYL HETEROCYCLES, Bioorganic & medicinal chemistry letters, 7(10), 1997, pp. 1359-1364
DESIGN, SYNTHESIS, AND EVOLUTION OF A NOVEL, SELECTIVE, AND ORALLY BIOAVAILABLE CLASS OF THROMBIN INHIBITORS - P1-ARGININAL DERIVATIVES INCORPORATING P3-P4 LACTAM SULFONAMIDE MOIETIES
Authors: SEMPLE JE ROWLEY DC BRUNCK TK HAUONG T MINAMI NK OWENS TD TAMURA SY GOLDMAN EA SIEV DV ARDECKY RJ CARPENTER SH GE Y RICHARD BM NOLAN TG HAKANSON K TULINSKY A NUTT RF RIPKA WC
Citation: Je. Semple et al., DESIGN, SYNTHESIS, AND EVOLUTION OF A NOVEL, SELECTIVE, AND ORALLY BIOAVAILABLE CLASS OF THROMBIN INHIBITORS - P1-ARGININAL DERIVATIVES INCORPORATING P3-P4 LACTAM SULFONAMIDE MOIETIES, Journal of medicinal chemistry, 39(23), 1996, pp. 4531-4536
EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS
Authors: ROTE WE DEMPSEY EM OLDESCHULTE GL ARDECKY RJ TAMURA SY NUTT RF BERGUM PW TRAN HS ANDERSON SM VLASUK GP
Citation: We. Rote et al., EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS, Circulation, 90(4), 1994, pp. 344-344
EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS
Authors: ROTE WE DEMPSEY EM OLDESCHULTE GL ARDECKY RJ TAMURA SY NUTT RF BERGUM PW TRAN HS ANDERSON SM VLASUK GP
Citation: We. Rote et al., EVALUATION OF A NOVEL ORALLY-ACTIVE DIRECT INHIBITOR OF THROMBIN IN ANIMAL-MODELS OF THROMBOSIS, Circulation, 90(4), 1994, pp. 344-344
Risultati: 1-7 |